Editorial Note: Tesla is the one stock in this market where the bear case and the bull case are both completely compelling — and they have nothing to do with each other. The bear case is Musk: DOGE brand damage, European boycott, and the possibility that the man running the company is also running it into the ground. The bull case is Terafab: a $25B semiconductor factory that, if real, makes Tesla a vertically integrated AI-hardware company. The stock at RSI 33 is your entry point to pick your side.

---

The Story Right Now

Tesla has now shed -26% from its 52-week high and is sitting at $369, almost exactly where it was a year ago when it traded around $259 — wait, actually the 12m data tells a different story. TSLA opened March 31, 2025 at $249 and is now at $369, meaning it's actually up roughly +42% over 12 months even after this significant pullback from the $498 52-week high. That context matters enormously. This is not a broken stock recovering from a multi-year collapse — it's a stock that ran to extreme highs on Musk enthusiasm and is now repricing on Musk backlash.

The -26% from 52wk highs arrived in two phases. Phase 1 (November 2025 through early March 2026): the golden cross led a rally to $498 as Musk's government role and FSD/Optimus narrative drove speculative interest. Phase 2 (March 2026): the macro hit everything, and TSLA got hit harder than most because Musk's political activities accelerated European brand damage in ways that the March 20 Reuters piece made concrete — "European sales rise for the first time in over a year, but still lag behind BYD." The "finally" in that headline carries a lot of weight.

The war-ends playbook has a specific TSLA call that's actually bearish in the near term: "EVs face a headwind when oil drops. When gas is $3/gallon instead of $5, the EV fuel savings argument weakens." That's the key counter-thesis here. The Iran conflict that's pushed oil to $130/barrel has also, paradoxically, made the EV value proposition easier to sell. If a ceasefire happens and oil drops to $70, the urgency for EV adoption fades. Tesla selling at premium prices to ICE alternatives needs the "fuel savings" math to work — and that math degrades sharply at lower oil prices.

But then there's Terafab. The March 23 news of a $25B semiconductor factory aimed at Tesla's AI capabilities is the most significant strategic announcement in years. If real and on schedule, this transforms Tesla from a company dependent on TSMC and NVIDIA for AI silicon into a vertically integrated AI hardware company. It changes the whole bull/bear framework. The problem is Tesla has a track record of announcing ambitious manufacturing projects and delivering them late and over budget. Terafab deserves healthy skepticism.

Today's bounce (+3.8%, from $355.28 to $369.02) reverses some of the brutal March 27-30 selloff. The stock breached its BB lower band ($356-$358) and found buyers. RSI at 33.6 is oversold but not extreme — MSFT and NVDA are in more distressed territory. The SMA20 at $387 is the first recovery target; getting back above it would signal the downtrend is losing momentum.

---

Quick Snapshot

---

Action Matrix

---

Price Data

30-day price narrative: TSLA opened March at $403, held the $400 level through mid-month, then broke down sharply on March 19-20 (losing $380 and $368 in two days on 78M+ volume). The March 23-25 dead-cat bounce back to $386 failed to reclaim the SMA200 area. March 27-30 saw a second leg down to $355 on continued heavy volume (62M-67M shares/day vs 61M average). Today's bounce on 46M volume is encouraging but not conclusive.

---

Company Overview

Tesla, Inc. ($1.38T market cap) — two reporting segments, many more narratives:

The market cap attribution is almost impossible to reconcile with traditional auto metrics. At $1.38T, TSLA is priced as an AI/autonomy company that also happens to make cars, not as an auto company with AI aspirations. The automotive business alone would justify maybe $150-200B. The rest is optionality pricing.

---

Competitive Analysis

BYD is the most important competitive threat. It's selling more EVs globally, pricing aggressively, and doesn't carry the Musk political risk premium. In Europe specifically, BYD is the winner from Tesla's brand damage.

---

Management

Musk concentration risk is the defining characteristic of TSLA as an investment. No other $1.4T company has this level of single-person dependency. The board has failed to create any governance structure independent of Musk. This is a feature (visionary execution) and a bug (brand/political risk, no succession plan).

---

Financials

The mixed Q4 results (March 22 news) confirm the core tension: automotive margins are under pressure from price competition and Musk's decision to cut prices to defend volume, while energy storage is a genuine growth engine. Tesla's bull case increasingly depends on energy + software, not just cars.

---

Valuation

TSLA valuation only makes sense if you believe in autonomous vehicles, humanoid robotics, and/or Terafab as transformational businesses. Pure automotive comp says the stock is worth 80% less. You don't buy TSLA for the cars.

---

Bull Case

1. Terafab announcement: $25B chip fab makes Tesla an AI infrastructure company, not just a car company
2. European sales finally turning positive after 13 months of decline — brand damage narrative may have peaked
3. Megapack/energy storage growing 50%+ YoY; becoming meaningful revenue (~$12B+ annualized pace)
4. FSD approaching commercial unsupervised deployment — the regulatory moat around robotaxi is real
5. RSI 33.6 with confirmed insider buying; meaningful technical oversold signal
6. 1Y return still +42% despite pullback — underlying trend is bullish
7. Optimus in limited production 2026; humanoid robotics could dwarf the car business

---

Bear Case

1. War ends → oil drops → EV urgency fades → near-term demand headwind at the worst possible time
2. Musk DOGE political risk: no off-switch. Each policy controversy creates a new cohort of Tesla boycotters
3. BYD eating global share; XPEV's ADAS matching FSD capability at a fraction of the price
4. Terafab is a multi-year capital sink; $25B on a chip factory while automotive margins are under pressure
5. Golden cross technically intact but SMA50 is declining toward SMA200 — death cross risk within weeks if no recovery
6. Q4 mixed results show the automotive business is decelerating; Musk's price cuts are a race to the bottom
7. RSI 33.6 is not extreme — no "must buy now" technical signal; could drift to 25 before real capitulation

---

Historical Price Events

---

Recent News

---

Related ETFs

---

Cross-References

• Watchlists: focus, ev-clean-energy, mag7, crypto (Musk correlated)
• War-ends EV headwind: the War-Ends Playbook perspective — bearish note on EVs
• Previous deep dive: the March 24 note
• EV scan context: the March 26 EV/clean-energy scan

---

Related Tickers

BYDDY, LI, NIO, XPEV (EV peers) | NVDA, AMD (AI chip suppliers) | ENPH, SEDG (EV-adjacent clean energy) | COIN, MSTR (Musk-sentiment correlated) | GOOGL/Waymo (autonomy competition)

---

Verdict

Tesla is uniquely difficult because there are two completely independent theses competing for the same stock price. Thesis A: Musk's political activities are creating permanent, compounding brand damage in the world's largest EV market (Europe), BYD is winning on price and quality, and a war-ends oil drop removes the fuel-savings tailwind. At RSI 33 and -26% from highs, thesis A is increasingly baked in but probably not fully priced — death cross risk remains if SMA50 rolls. Thesis B: Terafab + FSD + Optimus makes Tesla an AI infrastructure company valued on a completely different framework than autos, European sales are inflecting, and RSI 33 with insider buying is a contrarian entry. The stock itself doesn't let you hold both theses comfortably. The clearest read: wait for the golden cross / death cross resolution (likely within 2-3 weeks given current SMA convergence), and let price confirm which thesis is winning before adding aggressively. Current position management: hold existing exposure, no add until SMA20 recovery or clear death cross decision.

Updated 2026-03-31. Previous version archived as the March 24 note.

Sources

• Fundamentals figures: company-reported results (quarterly/annual filings) as available at the artifact date; predates the desk's EDGAR reconciliation gate — figures not re-verified after publication.